Synthesis and evaluation of 111In‐labeled tetrapeptide‐based compounds as single‐photon emission computed tomography imaging probes targeting granzyme B
-
Published:2023-05-29
Issue:10
Volume:66
Page:298-307
-
ISSN:0362-4803
-
Container-title:Journal of Labelled Compounds and Radiopharmaceuticals
-
language:en
-
Short-container-title:Labelled Comp Radiopharmac
Author:
Kazuta Nobuki1,
Watanabe Hiroyuki1ORCID,
Ono Masahiro1ORCID
Affiliation:
1. Department of Patho‐Functional Bioanalysis, Graduate School of Pharmaceutical Sciences Kyoto University Kyoto Japan
Abstract
Granzyme B is an attractive target as a biomarker for contributing to improve the treatment with immune checkpoint inhibitor (ICI). In this study, we designed novel 111In‐labeled granzyme B‐targeting single‐photon emission computed tomography (SPECT) imaging probes, [111In]IDT and [111In]IDAT. Nonradioactive In‐labeled granzyme B‐targeting compounds ([natIn]IDT, [natIn]IDAT) showed the affinity for recombinant mouse granzyme B. [111In]IDT and [111In]IDAT were obtained with moderate radiochemical yield and high stability in mouse plasma (>95%). In a biodistribution experiment using tumor‐bearing mice, [111In]IDT and [111In]IDAT showed moderate accumulation in tumor. Ex vivo autoradiography (ARG) indicated that the accumulation of radioactivity in tumor was correlated to expression of granzyme B confirmed by the immunohistochemical staining. These results indicated that [111In]IDT and [111In]IDAT showed the basic properties as granzyme B‐targeting SPECT probes.
Funder
Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering
Uehara Memorial Foundation
Subject
Organic Chemistry,Spectroscopy,Drug Discovery,Radiology, Nuclear Medicine and imaging,Biochemistry,Analytical Chemistry